U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 14:54:02 GMT 2023
Edited
by admin
on Sat Dec 16 14:54:02 GMT 2023
Protein Sub Type
Sequence Type COMPLETE
Record UNII
LD9PUL4TEM
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RAC-BETA SERINE/THREONINE-PROTEIN KINASE
Common Name English
PROTEIN KINASE B BETA
Common Name English
PROTEIN KINASE AKT-2
Common Name English
RAC-PK-BETA
Common Name English
PKB BETA
Common Name English
Code System Code Type Description
FDA UNII
LD9PUL4TEM
Created by admin on Sat Dec 16 14:54:02 GMT 2023 , Edited by admin on Sat Dec 16 14:54:02 GMT 2023
PRIMARY
UNIPROT
P31751
Created by admin on Sat Dec 16 14:54:02 GMT 2023 , Edited by admin on Sat Dec 16 14:54:02 GMT 2023
PRIMARY
PHAROS
P31751
Created by admin on Sat Dec 16 14:54:02 GMT 2023 , Edited by admin on Sat Dec 16 14:54:02 GMT 2023
PRIMARY
From To
1_60 1_77
1_297 1_311
Glycosylation Type HUMAN
Glycosylation Link Type Site
O 1_128
O 1_131
O 1_306
O 1_313
Related Record Type Details
INHIBITOR -> TARGET
INHIBITOR -> TARGET
ALLOSTERIC
IC50
INHIBITOR -> TARGET
ALLOSTERIC INHIBITOR
IC50
INHIBITOR -> TARGET
INHIBITOR -> TARGET
ALLOSTERIC
INHIBITOR -> TARGET
Notably, the antitumor effect of miR-193a-3p transfection in glioma cells may be due to the miR-193a-3p–induced inhibition of AKT2 expression caused by the suppression of ALKBH5 expression.
PRECLINICAL
INHIBITOR -> TARGET
AT 10mM ATP and 36 nM at 2 mM ATP)
INHIBITOR -> TARGET
INHIBITOR -> TARGET
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL